{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:53:44Z","timestamp":1772643224265,"version":"3.50.1"},"reference-count":36,"publisher":"Bentham Science Publishers Ltd.","issue":"15","funder":[{"DOI":"10.13039\/501100001501","name":"University Grant Commission","doi-asserted-by":"publisher","award":["F.25-1\/2013-14(BSR)\/7-344\/ 2011"],"award-info":[{"award-number":["F.25-1\/2013-14(BSR)\/7-344\/ 2011"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2019,11,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The diazenyl compounds (-N=N- linkage) have been reported to have antimicrobial\nactivity. In modern drug discovery, the drug-receptor interactions are generally explored by the\nmolecular docking studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and Methods:<\/jats:title>\n<jats:p>Three categories of diazenyl scaffolds were screened for the docking studies\nto explore the binding mechanism of interaction with various microbial targets. The diazenyl Schiff\nbases (SBN-20, SBN-21, SBN-25, SBN-33, SBN-39, SBN-40 and SBN-42), naphthol pharmacophore\nbased diazenyl Schiff bases (NS-2, NS-8, NS-12, NS-15, NS-21, and NS-23), morpholine based diazenyl\nchalcones (MD-6, MD-9, MD-14, MD-16, MD-20, and MD-21) were docked against various\nbacterial and fungal proteins in comparison with different standard drugs. Further, the drug likeliness\nand ADME properties of these molecules were predicted by QikProp module of the Schrodinger software.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> Most of the derivatives had shown less docking scores and binding energies towards bacterial\nproteins, such as dihydropteroate synthase (PDB:2VEG), glucosamine-6-phosphate synthase\n(PDB:2VF5), dihydrofolate reductase (PDB:3SRW) in comparison with the standard drugs. The naphthol\nbased diazenyl Schiff bases NS-21 and NS-23 were predicted to act on the cytochrome P450 sterol\n14-alpha-demethylase (CYP51) (PDB:5FSA) involved in sterol biosynthesis, an essential target for\nantifungal drugs. The derivative MD-6, NS-2, NS-21, and NS-23 had shown high docking scores\nagainst bacterial DNA topoisomerase (PDB:3TTZ) in comparison with the standard drug ciprofloxacin.\nFurther, most of the synthesized derivatives had shown drug like characters.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Hence, these compounds can be developed as novel antibacterial agents as potent DNA\ntopoisomerase inhibitors and antifungal agents as CYP51 inhibitors.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450120666190618122359","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T08:27:14Z","timestamp":1560932834000},"page":"1587-1602","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Molecular Docking Study of Active Diazenyl Scaffolds as Inhibitors of Essential Targets Towards Antimicrobial Drug Discovery"],"prefix":"10.2174","volume":"20","author":[{"given":"Harmeet","family":"Kaur","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak-124001, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Gahlawat","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak-124001, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasbir","family":"Singh","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Postgraduate Institute of Medical Sciences, Rohtak-124001, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balasubramanian","family":"Narasimhan","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak-124001, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"56","volume":"14","author":"Adedeji W.A.","year":"2016","unstructured":"Adedeji W.A.; The treasure called antibiotics. Ann Ib Postgrad Med 2016,14(2),56-57","journal-title":"Ann Ib Postgrad Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/ja.2008.16","volume":"62","author":"Demain A.L.","year":"2009","unstructured":"Demain A.L.; Sanchez S.; Microbial drug discovery: 80 years of progress. J Antibiot (Tokyo) 2009,62(1),5-16","journal-title":"J Antibiot (Tokyo)"},{"key":"ref=3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030176","volume":"3","author":"Cirz R.T.","year":"2005","unstructured":"Cirz R.T.; Chin J.K.; Andes D.R.; de Cr\u00e9cy-Lagard V.; Craig W.A.; Romesberg F.E.; Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol 2005,3(6)","journal-title":"PLoS Biol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1465-0691.2004.1004.x","volume":"10","author":"Livermore D.M.","year":"2004","unstructured":"Livermore D.M.; The need for new antibiotics. Clin Microbiol Infect 2004,10(Suppl. 4),1-9","journal-title":"Clin Microbiol Infect"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"Prestinaci F.","year":"2015","unstructured":"Prestinaci F.; Pezzotti P.; Pantosti A.; Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 2015,109(7),309-318","journal-title":"Pathog Glob Health"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrmicro3380","volume":"13","author":"Blair J.M.","year":"2015","unstructured":"Blair J.M.; Webber M.A.; Baylay A.J.; Ogbolu D.O.; Piddock L.J.; Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 2015,13(1),42-51","journal-title":"Nat Rev Microbiol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1001\/archinte.1991.00400050040010","volume":"151","author":"Dever L.A.","year":"1991","unstructured":"Dever L.A.; Dermody T.S.; Mechanisms of bacterial resistance to antibiotics. Arch Intern Med 1991,151(5),886-895","journal-title":"Arch Intern Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/PMC.S14459","volume":"6","author":"Fair R.J.","year":"2014","unstructured":"Fair R.J.; Tor Y.; Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem 2014,6,25-64","journal-title":"Perspect Medicin Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1586\/14787210.3.6.907","volume":"3","author":"Zinner S.H.","year":"2005","unstructured":"Zinner S.H.; The search for new antimicrobials: why we need new options. Expert Rev Anti Infect Ther 2005,3(6),907-913","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"Meng X.Y.","year":"2011","unstructured":"Meng X.Y.; Zhang H.X.; Mezei M.; Cui M.; Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 2011,7(2),146-157","journal-title":"Curr Comput Aided Drug Des"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1367-5931(02)00339-3","volume":"6","author":"Shoichet B.K.","year":"2002","unstructured":"Shoichet B.K.; McGovern S.L.; Wei B.; Irwin J.J.; Lead discovery using molecular docking. Curr Opin Chem Biol 2002,6(4),439-446","journal-title":"Curr Opin Chem Biol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00894-002-0112-y","volume":"9","author":"Schulz-Gasch T.","year":"2003","unstructured":"Schulz-Gasch T.; Stahl M.; Binding site characteristics in structure-based virtual screening: evaluation of current docking tools. J Mol Model 2003,9(1),47-57","journal-title":"J Mol Model"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2298\/JSC0702119D","volume":"72","author":"Dixit B.C.","year":"2007","unstructured":"Dixit B.C.; Patel H.; Desai D.J.; Synthesis and application of new mordent and disperse azo dyes based on 2, 4-dihydroxybenzophenone. J Serb Chem Soc 2007,72(2),119-127","journal-title":"J Serb Chem Soc"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/10590501.2016.1236602","volume":"34","author":"Chung K.T.","year":"2016","unstructured":"Chung K.T.; Azo dyes and human health: A review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2016,34(4),233-261","journal-title":"J Environ Sci Health C Environ Carcinog Ecotoxicol Rev"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/10408419209114557","volume":"18","author":"Chung K.T.","year":"1992","unstructured":"Chung K.T.; Stevens S.E.; Cerniglia C.E.; The reduction of azo dyes by the intestinal microflora. Crit Rev Microbiol 1992,18(3),175-190","journal-title":"Crit Rev Microbiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.2174\/1568026618666180626095714","volume":"18","author":"Kaur H.","year":"2018","unstructured":"Kaur H.; Narasimhan B.; Synthesis, Characterization, antimicrobial and antioxidant potential of diazenyl chalcones. Curr Top Med Chem 2018,18(10),844-856","journal-title":"Curr Top Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.2174\/1871520616666160607012042","volume":"16","author":"Kaur H.","year":"2016","unstructured":"Kaur H.; Yadav S.; Narasimhan B.; Diazenyl derivatives and their complexes as anticancer agents. Anticancer Agents Med Chem 2016,16(10),1240-1265","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1568026618666180206093107","volume":"18","author":"Kaur H.","year":"2018","unstructured":"Kaur H.; Narasimhan B.; Antimicrobial activity of diazenyl derivatives: an update. Curr Top Med Chem 2018,18(1),3-21","journal-title":"Curr Top Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2017.05.004","author":"Kaur H.","year":"2017","unstructured":"Kaur H.; Lim S.M.; Ramasamy K.; Vasudevan M.; Shah S.A.; Narasimhan B.; Diazenyl schiff bases: synthesis, spectral analysis, antimicrobial studies and cytotoxic activity on human colorectal carcinoma cell line (HCT-116). Arab J Chem 2017","journal-title":"Arab J Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.2174\/1871520618666180830152701","volume":"18","author":"Kaur H.","year":"2018","unstructured":"Kaur H.; Desai S.D.; Singh J.; Narasimhan B.; Morpholine based diazenyl chalcones: Synthesis, antimicrobial screening and cytotoxicity study. Anticancer Agents Med Chem 2018,18(15),2193-2205","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-019-0558-y","author":"Kaur H.","unstructured":"Kaur H.; Singh J.; Narasimhan B.; Synthesis of novel naphthol diazenyl scaffold based Schiff bases as potential antimicrobial and cytotoxic agents against human colorectal carcinoma cell line (HT-29). BMC Chemistry In Press","journal-title":"BMC Chemistry"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3390\/molecules19021672","volume":"19","author":"Alves M.J.","year":"2014","unstructured":"Alves M.J.; Froufe H.J.; Costa A.F.; Docking studies in target proteins involved in antibacterial action mechanisms: extending the knowledge on standard antibiotics to antimicrobial mushroom compounds. Molecules 2014,19(2),1672-1684","journal-title":"Molecules"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s00044-016-1519-9","volume":"25","author":"Shaikh M.H.","year":"2016","unstructured":"Shaikh M.H.; Subhedar D.D.; Shingate B.B.; Synthesis, biological evaluation and molecular docking of novel coumarin incorporated triazoles as antitubercular, antioxidant and antimicrobial agents. Med Chem Res 2016,25(4),790-804","journal-title":"Med Chem Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1021\/jm700967e","volume":"51","author":"O\u2019Shea R.","year":"2008","unstructured":"O\u2019Shea R.; Moser H.E.; Physicochemical properties of antibacterial compounds: implications for drug discovery. J Med Chem 2008,51(10),2871-2878","journal-title":"J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00044-010-9329-y","volume":"20","author":"Pawar V.S.","year":"2011","unstructured":"Pawar V.S.; Lokwani D.K.; Bhandari S.V.; Design, docking study and ADME prediction of Isatin derivatives as anti-HIV agents. Med Chem Res 2011,20(3),370-380","journal-title":"Med Chem Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jmb.2008.01.077","volume":"377","author":"Mouilleron S.","year":"2008","unstructured":"Mouilleron S.; Badet-Denisot M.A.; Golinelli-Pimpaneau B.; Ordering of C-terminal loop and glutaminase domains of glucosamine-6-phosphate synthase promotes sugar ring opening and formation of the ammonia channel. J Mol Biol 2008,377(4),1174-1185","journal-title":"J Mol Biol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.1016\/j.bmcl.2011.10.010","volume":"21","author":"Sherer B.A.","year":"2011","unstructured":"Sherer B.A.; Hull K.; Green O.; Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy. Bioorg Med Chem Lett 2011,21(24),7416-7420","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1042\/BJ20071598","volume":"412","author":"Levy C.","year":"2008","unstructured":"Levy C.; Minnis D.; Derrick J.P.; Dihydropteroate synthase from Streptococcus pneumoniae: structure, ligand recognition and mechanism of sulfonamide resistance. Biochem J 2008,412(2),379-388","journal-title":"Biochem J"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1016\/j.bmcl.2011.07.059","volume":"21","author":"Li X.","year":"2011","unstructured":"Li X.; Hilgers M.; Cunningham M.; Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquina- zolines. Bioorg Med Chem Lett 2011,21(18),5171-5176","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1093\/emboj\/16.12.3416","volume":"16","author":"Bertrand J.A.","year":"1997","unstructured":"Bertrand J.A.; Auger G.; Fanchon E.; Crystal structure of UDP-N-acetylmuramoyl-L-alanine: D-glutamate ligase from Escherichia coli. EMBO J 1997,16(12),3416-3425","journal-title":"EMBO J"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1021\/jm300395d","volume":"55","author":"Brvar M.","year":"2012","unstructured":"Brvar M.; Perdih A.; Renko M.; Anderluh G.; Turk D.; Solmajer T.; Structure-based discovery of substituted 4,5\u2032-bithiazoles as novel DNA gyrase inhibitors. J Med Chem 2012,55(14),6413-6426","journal-title":"J Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"6728","DOI":"10.1074\/jbc.M117.778308","volume":"292","author":"Hargrove T.Y.","year":"2017","unstructured":"Hargrove T.Y.; Friggeri L.; Wawrzak Z.; Structural analyses of Candida albicans sterol 14\u03b1-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. J Biol Chem 2017,292(16),6728-6743","journal-title":"J Biol Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1073\/pnas.061562898","volume":"98","author":"Podust L.M.","year":"2001","unstructured":"Podust L.M.; Poulos T.L.; Waterman M.R.; Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci USA 2001,98(6),3068-3073","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1021\/cb5008647","volume":"10","author":"Fang W.","year":"2015","unstructured":"Fang W.; Robinson D.A.; Raimi O.G.; N-myristoyltransferase is a cell wall target in Aspergillus fumigatus. ACS Chem Biol 2015,10(6),1425-1434","journal-title":"ACS Chem Biol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","volume":"44","author":"Lipinski C.A.","year":"2000","unstructured":"Lipinski C.A.; Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000,44(1),235-249","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/17460441.2017.1344210","volume":"12","author":"Tsopelas F.","year":"2017","unstructured":"Tsopelas F.; Giaginis C.; Tsantili-Kakoulidou A.; Lipophilicity and biomimetic properties to support drug discovery. Expert Opin Drug Discov 2017,12(9),885-896","journal-title":"Expert Opin Drug Discov"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/172721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T08:26:58Z","timestamp":1574929618000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/172721\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":36,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2019,11,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450120666190618122359","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-03-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}